Table 5.
Pearson correlations for the combined groups between the change in baseline (%) of inflammation markers during glucose challenge after DHEA or placebo administration to each other that signify the posttreatment response to glucose ingestion
| RNA Content (%Change) |
Protein Content (%Change) |
||||||
|---|---|---|---|---|---|---|---|
| p65 | p105 | TNFα | IL-1β | p65 | IκB | Plasma TNFα (%Change) | |
| Intranuclear | |||||||
| NF-κB NF-κB (%Change) | |||||||
| r | 0.582 | 0.253 | 0.383 | 0.320 | 0.615 | −0.524 | 0.215 |
| P | 0.023* | 0.345 | 0.144 | 0.267 | 0.011* | 0.037* | 0.460 |
| p65 | |||||||
| r | 0.729 | 0.758 | 0.457 | 0.368 | 0.303 | 0.303 | |
| P | 0.002* | 0.001* | 0.087 | 0.177 | 0.314 | 0.314 | |
| p105 | |||||||
| r | 0.573 | 0.554 | 0.145 | 0.393 | 0.393 | ||
| P | 0.020* | 0.026* | 0.592 | 0.165 | 0.165 | ||
| TNFα | |||||||
| r | 0.177 | 0.652 | 0.504 | 0.504 | |||
| P | 0.513 | 0.006* | 0.066 | 0.066 | |||
| IL-1β | |||||||
| r | 0.206 | 0.352 | 0.137 | ||||
| P | 0.444 | 0.181 | 0.640 | ||||
P < 0.05.